- Home
- HRTX vs FTF Comparison
HRTX vs FTF Comparison
Compare HRTX & FTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HRTX | FTF |
|---|---|---|
| Founded | 1983 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 265.9M | 250.9M |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | HRTX | FTF |
|---|---|---|
| Price | $1.28 | $6.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.50 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 153.9K |
| Earning Date | 02-26-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 11.45% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $155,097,000.00 | N/A |
| Revenue This Year | $8.98 | N/A |
| Revenue Next Year | $11.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 12.60 | N/A |
| 52 Week Low | $1.00 | $5.76 |
| 52 Week High | $2.68 | $6.56 |
Technical Indicators
Market Signals| Indicator | HRTX | FTF |
|---|---|---|
| Relative Strength Index (RSI) | 43.85 | 56.09 |
| Support Level | $1.19 | $6.15 |
| Resistance Level | $1.42 | $6.29 |
| Average True Range (ATR) | 0.07 | 0.04 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 30.65 | 46.67 |
Price Performance
Historical ComparisonAbout HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About FTF Franklin Limited Duration Income Trust of Beneficial Interest
Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.